Ampliphi Biosciences Corp (APHB) SEC Filing 8-K Material Event for the period ending Tuesday, January 9, 2018

Ampliphi Biosciences Corp

CIK: 921114 Ticker: APHB

View differences made from one to another to evaluate Ampliphi Biosciences Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Ampliphi Biosciences Corp.


Assess how Ampliphi Biosciences Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Ampliphi Biosciences Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors



Material Contracts, Statements, Certifications & more

Ampliphi Biosciences Corp provided additional information to their SEC Filing as exhibits

Ticker: APHB
CIK: 921114
Form Type: 8-K Corporate News
Accession Number: 0001144204-18-002105
Submitted to the SEC: Fri Jan 12 2018 4:15:20 PM EST
Accepted by the SEC: Fri Jan 12 2018
Period: Tuesday, January 9, 2018
Industry: Biological Products No Disgnostic Substances
  1. Financial Exhibit
  2. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: